Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results Tuesday, 22 September 2026 04:05 PM Earnings Fourth quarter fiscal 2026 net revenue increased 6.4% to $16.1 million from $15.1 million in the prior-year quarter Fourth quarter fiscal 2026 Adjusted EBITDA of $0.5 million EXXUA net revenue of $6.6 million in fiscal 2026, including $3.9 million in the fourth quarter, ...